Showing results (41-50 of 45) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancers|July 18, 2020
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast CancerGaia Griguolo, Fara Brasó-Maristany, Blanca González-Farré, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- TrialMonika Graeser, Oleg Gluz, Claudia Biehl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP TrialNadia Harbeck, Ulrike A Nitz, Matthias Christgen, et al.Thrombosis and Haemostasis|September 6, 2003
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patientsMaxime Look, Wim van Putten, Michael Duffy, et al.Journal of the National Cancer Institute|January 17, 2002
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsMaxime P Look, Wim L J van Putten, Michael J Duffy, et al.Pageof 5